Pancreatic Cancer Research

ResearcherUniversity of California, DavisActive in the last 2 years

Edward J Kim

Verified by NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on NIH RePORTER profile ID 3133598. Sources: ClinicalTrials.gov.

Their work

Papers
0
Trials
2 (principal investigator on 2)
Grants
1
Labs led
0
Collaborators
3
Papers, trials and grants by year

2019: 1 trial · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 trial · 2026: 1 grant

Trials 2

  1. TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma Principal investigator NCT07189195↗
  2. SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic Cancer Principal investigator NCT04050085↗

Grants 1

  1. TGX-1214 - Combination Strategy for the Treatment of Advanced Pancreatic Cancer R01CA269233↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. James E Egan · 1 shared grant, 2026 · strength 0.86
  2. Mansoor M. Amiji · 1 shared grant, 2026 · strength 0.86
  3. Gerardo Guillermo Mackenzie · 1 shared grant, 2026 · strength 0.86

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.